Literature DB >> 9104801

Extremely high serum level of IgE during immunosuppressive therapy: paradoxical effect of cyclosporine A and tacrolimus.

N Kawamura1, H Furuta, A Tame, I Kobayashi, T Ariga, M Okano, Y Sakiyama.   

Abstract

A case of X-linked autoimmune enteropathy was successfully treated with cyclosporine A (CsA) or tacrolimus (FK506) and developed extremely high serum levels of IgE during the immunosuppressive therapy. Serum IgE levels increased from 190 to 1,000-2,500 IU/ml with CsA therapy and as high as 80,000 IU/ml with subsequent FK506 therapy. Serum IgG2 and IgG4 levels were slightly elevated compared to serum IgE levels. Thereafter, serum IgE levels progressively decreased in parallel with a reduced dosage of FK506. Total serum IgG levels and peripheral eosinophil counts, however, showed no significant changes during the course. These observations suggest that both CsA and FK506, potent immunosuppressants, could paradoxically enhance some immune responses, possibly through the action of CsA-/FK506-resistant immune systems.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9104801     DOI: 10.1159/000237491

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  4 in total

1.  New-onset food allergy following cord blood transplantation in adult patients.

Authors:  T Mori; J Kato; M Sakurai; N Hashimoto; S Kohashi; R Hashida; M Saburi; T Kikuchi; Y Yamane; K Hoshino; S Okamoto
Journal:  Bone Marrow Transplant       Date:  2015-10-12       Impact factor: 5.483

2.  Low-dose cyclosporine A in a patient with X-linked immune dysregulation, polyendocrinopathy and enteropathy.

Authors:  Hiroshi Tanaka; Koji Tsugawa; Masanobu Kudo; Kazuhiko Sugimoto; Ichiro Kobayashi; Etsuro Ito
Journal:  Eur J Pediatr       Date:  2005-08-10       Impact factor: 3.183

3.  Calcineurin inhibitors dampen humoral immunity by acting directly on naive B cells.

Authors:  R De Bruyne; D Bogaert; N De Ruyck; B N Lambrecht; M Van Winckel; P Gevaert; M Dullaers
Journal:  Clin Exp Immunol       Date:  2015-06       Impact factor: 4.330

4.  New developments in transplant-acquired allergies.

Authors:  Oner Ozdemir
Journal:  World J Transplant       Date:  2013-09-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.